Brussels, Belgium
December 20, 2005The
European Commission today presents “100 Technology offers
stemming from EU Biotechnology RTD results”, a catalogue of
biotechnology developments arising from EU-funded research
projects over the last 10 years. This guide will help to put
researchers and companies in contact, hopefully leading to new
and innovative products and processes based on this research.
Examples featured in the catalogue include applications for food
and plant biotechnology, biopharmaceuticals and biomedical
technologies to support diagnostics and therapy. Each technology
offer is described, including its potential for future
commercial exploitation, and contact details are given for the
researchers and the owners. “100 Technology Offers” is an
example of how the European Commission is supporting the
transformation of research into innovation.
“Growth and jobs are fuelled by
innovation and innovation is fed by research”, said Janez
Potočnik, European Commissioner for Science and Research. “With
this publication, the Commission is helping researchers to make
their results known and put new technologies at the disposal of
industry that can make the most of them.”
“100 biotechnology offers”
includes results from the 4th, 5th and 6th Framework Programmes.
Examples include:
- A small Slovenian company,
BIA separations, which recently defended its intellectual
property at the European Patent Office against big industry.
The issue is one of monolithic chromatographic supports,
which are used for the purification of pharmaceuticals and
biologicals;
- Belgian start-up
Cilbiotech, which improves the scale-up of cell cultivation
for the production of human and veterinary vaccines. This
new technology can for example increase the coverage of
vaccines that may not currently be available to some
sections of the population due to allergies.
All examples show that
technologies developed by small biotech companies are ripe for
future exploitation, and that issues relating to intellectual
property need to be resolved if this is to take place in the
best way.
Over the last 5-10 years, the
Commission has required projects to develop a technological
implementation plan, as part of making scientists aware of
issues relating to intellectual property and entrepreneurship.
An online version of the
booklet can be downloaded from:
http://www.cordis.europa.eu.int/lifescihealth/src/leaflet.htm
|